Sonoma Pharmaceuticals, Inc.
SNOA
$3.24
-$0.03-0.92%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 56.97% | -59.92% | 16.38% | -52.13% | 46.63% |
| Total Depreciation and Amortization | 0.00% | 16.13% | -6.06% | -5.71% | -10.26% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 147.99% | -165.93% | 7,633.33% | -104.72% | -55.28% |
| Change in Net Operating Assets | 45.31% | -358.59% | -86.49% | 82.79% | 971.74% |
| Cash from Operations | 68.49% | -2,021.05% | -116.81% | 59.60% | 138.82% |
| Capital Expenditure | 90.57% | -125.53% | -2,250.00% | 92.31% | -420.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 90.57% | -125.53% | -2,250.00% | 92.31% | -420.00% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -2.47% | 0.00% | 1.22% | 32.79% | -2.52% |
| Issuance of Common Stock | -8.70% | -53.06% | -93.80% | -49.59% | 107.55% |
| Repurchase of Common Stock | -- | -- | -- | 100.00% | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -6.90% | -123.97% | -65.82% | -50.97% | 127.04% |
| Foreign Exchange rate Adjustments | -66.59% | 978.95% | 133.63% | 60.07% | -9.69% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 67.78% | -1,381.88% | -88.08% | -22.23% | 376.25% |